×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [168]
复旦大学上海医学... [153]
山东大学 [122]
合肥物质科学研究院 [90]
西安交通大学 [55]
上海药物研究所 [52]
更多...
内容类型
期刊论文 [971]
会议论文 [82]
学位论文 [14]
发表日期
2023 [2]
2022 [26]
2021 [40]
2020 [37]
2019 [135]
2018 [168]
更多...
学科主题
Oncology [10]
Pharmacolo... [5]
Respirator... [4]
Biochemist... [3]
Cell Biolo... [3]
Chemistry;... [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共1067条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers
期刊论文
CANCER LETTERS, 2024, 卷号: 582, 页码: 15
作者:
Lu, Xuxiu
;
Yu, Rilei
;
Li, Zhen
;
Yang, Mengke
;
Dai, Jiajia
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2024/04/07
Acquired resistance
Cancer
NSCLC
JC-010a
SHP2
A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
期刊论文
BMC PULMONARY MEDICINE, 2023, 卷号: 23, 期号: 1
作者:
Bing Han
;
Yanrong Kang
;
Haiji Wang
;
Jian Wang
;
Rong Shen
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2024/01/26
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I
期刊论文
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:
Yuankai Shi
;
Jianying Zhou
;
Yanqiu Zhao
;
Bo Zhu
;
Liangming Zhang
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/07
Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study
期刊论文
EBIOMEDICINE, 2022, 卷号: 86, 页码: 13
作者:
She, Yunlang
;
He, Bingxi
;
Wang, Fang
;
Zhong, Yifan
;
Wang, Tingting
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2023/02/22
Deep learning
Neoadjuvant chemoimmunotherapy
Major pathological response
Non-small cell lung cancer
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H
期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:
Guo, Huihui
;
Zhang, Xilin
;
Xie, Shangzhi
;
Chen, Tianwei
;
Xie, Dong
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/22
gefitinib
CD28H
NSCLC
EGFR mutation
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
期刊论文
CANCER MEDICINE, 2022
作者:
Yu, Xiaoqing
;
Si, Jinfei
;
Wei, Jingwen
;
Wang, Yanling
;
Sun, Yan
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
EGFR-TKIs
non-small cell lung cancer (NSCLC)
real-world study
survival outcome
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wei, Jingwen
;
Xiang, Jing
;
Hao, Yue
;
Si, Jinfei
;
Wang, Wenxian
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/22
Anemia
Epidermal growth factor receptor
Epidermal growth factor receptor tyrosine kinase inhibitors
Non-small cell lung cancer
Pulmonary Epithelial-Myoepithelial Carcinoma
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Chen, Lingru
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Pulmonary Large Cell Neuroendocrine Carcinoma
期刊论文
PATHOLOGY & ONCOLOGY RESEARCH, 2022, 卷号: 28
作者:
Yang, Lan
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
treatment
diagnosis
LCNEC
imaging examination
pathologic features
prognosis
The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how
期刊论文
FUTURE ONCOLOGY, 2022
作者:
Zhou, Suna
;
Meng, Yinnan
;
Sun, Xuefeng
;
Jin, Zhicheng
;
Feng, Wei
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2022/12/22
ART
how
NSCLC
when
who
©版权所有 ©2017 CSpace - Powered by
CSpace